RICHARDSON & ASSOCIATES ATTORNEYS AT LAW |
August 5, 2019
Via: EDGAR
United States
Securities and Exchange Commission
Division of Corporate Finance
Office of Healthcare & Insurance
100 F Street, N.E.
Washington, D.C. 20549
Attention: | Jeffrey Gabor, Esq., Special Counsel |
| Re: | Med-X, Inc. |
| | Pre-Qualification Amendment Number Three to Offering Statement on Form 1-A SEC File No. 024-11007 Originally filed on July 1, 2019 |
Dear Mr. Gabor,
We respectfully request, as legal counsel on behalf of Med-X, Inc., that the above referenced Offering Statement on Form 1-A be declared qualified by the Securities and Exchange Commission, effective at 11:00 AM Eastern Daylight Time on Monday, August 12, 2019. The Financial Industry National Regulatory Authority (“FINRA”) has issued its no objection letter to Med-X, Inc.’s placement agent, NMS Capital Advisors, LLC, effective August 5, 2019.
| Very Truly Yours, | |
| | |
| /s/ Mark J. Richardson | |
| Mark J. Richardson | |
| for | |
| Richardson & Associates | |
| | |
cc: Ronald Tchorzewski, Chief Financial Officer | | |
Matthew Mills, President | | |
1453 THIRD STREET PROMENADE, SUITE 315, SANTA MONICA, CALIFORNIA 90401
TELEPHONE (310) 393-9992 FACSIMILE (310) 393-2004